Teva Pharmaceutical Industries (NYSE:TEVA)

Top Analyst Upgrades and Downgrades: Best Buy, Equifax, Gilead, MongoDB, NVIDIA, Rio Tinto, Teva, UPS and More

Stocks were indicated to open lower on Monday, with all major U.S. equity indexes down about 0.3% on average. What investors still need to consider is that the stock indexes ...
Read Full Story »

Short Sellers Back Way Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Teva, General Electric Scoot into Thursday’s 52-Week Low Club

November 2, 2017: Here are four stocks trading with heavy volume among 151 equities making new 52-week lows in Thursday's session. On the NYSE, advancers and decliners traded evenly and ...
Read Full Story »

Teva Earnings Send Shares to New Low Not Seen in Over a Decade

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent quarterly results before the markets opened on Thursday. Teva has faced a lot of difficulty this year, and really since ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

The beginning of October not only ushered in the fourth quarter, but a time of the year when the markets can be volatile. The bull run approached nine years long, ...
Read Full Story »

PG&E, Teva Pharmaceuticals Dive into Friday’s 52-Week Low Club

October 13, 2017: Here are four stocks trading with heavy volume among 64 equities making new 52-week lows in Friday's session. On the NYSE, advancers led decliners by less than ...
Read Full Story »

JC Penney, General Electric Topple Into Thursday’s 52-Week Low Club

October 12, 2017: Here are four stocks trading with heavy volume among 61 equities making new 52-week lows in Thursday's session. On the NYSE, advancers led decliners by less than ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Interest Piles On

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: ASML, GE, HubSpot, Infosys, Teva, United Continental and Many More

Stocks were indicated to open higher on Monday after last week seeing new all-time highs for the major equity indexes. No earth-shattering news over the weekend kept investors positive. Those same investors ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, ADM, Citigroup, Gap, Kroger, Nike, Nucor, Rite Aid, Teva, Under Armour and More

Stocks were indicated to open higher again on Tuesday after strong gains on Monday. Investors should keep in mind that the major stock indexes still remain close to all-time highs. Another ...
Read Full Story »

Can a New CEO Turn Around Teva?

Executive management teams are a fundamental component on how a company runs. And often companies that lose their way or that are facing adversity may need a change at the ...
Read Full Story »

HP Enterprise, Qualcomm Shamble into Wednesday’s 52-Week Low Club

September 6, 2017: Here are four stocks trading with heavy volume among 74 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by nearly 3 ...
Read Full Story »